Validity of the French Version of the Quality of Life Questionnaire

Status Withdrawn

Clinical Trial Summary

Clinical Trial Description

The World Health Organization estimates that chronic otitis media could reach between 65 and 350 million people worldwide and thus be an important cause of medical consultation and prescription drugs. The medical care of chronic otitis is difficult, despite several medical and surgical treatment options. Moreover this pathology is often recurrent. The completion of a standardized questionnaire to track symptoms objectively over time is fundamental to verify the efficacy of specific treatments and to compare treatments. The quality of life measurement questionnaire related to chronic otitis media (COMQ-12) is a new questionnaire, validated in English, to assist the physician in evaluating chronic otitis media. The original version of the COMQ12 questionnaire, in English, was developed by Phillips et al.. The construction of this questionnaire was based on three other questionnaires : the Chronic Ear Survey (CES), the Chronic Otitis Media Outcome-15 (COMOT-15), and the Chronic Otitis Media-5 (COM-5). The initial validation of the English version of Phillips et al. was evaluated with an alpha value of Cronbach to 0.889, which shows high internal consistency and would allow its use in several reputed international centers of otology. The objective of this study is to translate and validate the test in French in children. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04423952
Study type	Observational
Source	Assistance Publique - Hôpitaux de Paris
Contact
Status	Withdrawn
Phase
Start date	July 2021
Completion date	July 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03294421` - Combined Access Closed Tympanomastoidectomy: Microsurgery Allied to Endoscopy	N/A
Completed	`NCT01855425` - Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose	N/A
Not yet recruiting	`NCT01157910` - Bacterial Assessment of Middle Ear Fluid in Children Undergoing Ventilation Tube Placement Surgery	N/A
Completed	`NCT02226718` - Validation of a Questionnaire for Measuring Quality of Life in Patients With Chronic Inflammation of the Middle Ear
Not yet recruiting	`NCT06398899` - Sugammadex v.s. Neostigmine/Glycopyrrolate	N/A
Completed	`NCT02495038` - Optimal Dose of Combination of Rocuronium and Cisatracurium	N/A
Completed	`NCT01251432` - Risk Factors and Potential Causes of Eustachian Tube Dysfunction in Adults	N/A
Active, not recruiting	`NCT00271778` - A Comparative Study of the Outcomes of 2 Surgical Procedures for Safe Type of Chronic Otitis Media	Phase 3
Active, not recruiting	`NCT00270660` - A Study of the Clinicopathologic Behaviour of the Different Types of Unsafe Chronic Otitis Media	Phase 3
Completed	`NCT01188551` - Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement	Phase 2/Phase 3
Completed	`NCT04374266` - Tegmen Defect Management During Mastoidectomy
Completed	`NCT00189098` - Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media	N/A
Completed	`NCT04864912` - Retrospective Health Care Utilisation and Current Quality of Life in Adults With Chronic Otitis Media Who Had a Middle Ear Surgery
Active, not recruiting	`NCT04396145` - The Effects of Chronic Otitis Surgery on SVV
Completed	`NCT02716376` - Treatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following Radiotherapy	N/A
Completed	`NCT00941993` - Anesthetic Effect of Lidocaine/Epinephrine Solution Delivered Via Iontophoresis to External Auditory Apparatus	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Validity of the French Version of the Quality of Life Questionnaire COMQ12-FR — COMQ12-FR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms